Skip to content

Does Islet Transplantation Eliminate Hypoglycemia?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00006068
Enrollment
Unknown
Registered
2000-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

Low blood sugar (hypoglycemia) is a recurrent problem for many people with diabetes. Successful transplantation of clusters (islets) of normal cells, that include those which produce the sugar-lowering hormone insulin, from the pancreas of a person who did not have diabetes into a person with diabetes should eliminate high blood sugar levels. We wish to determine if it will also eliminate low blood sugar. To do so we will give insulin to lower the blood sugar, measure the levels of the hormones that normally raise blood sugar levels (e.g., glucagon and epinephrine) and then stop the insulin and see if blood sugar levels return to normal. Because we anticipate that the transplanted islets will produce insulin, but not glucagon, this study may also tell us if regulated insulin production alone can prevent hypoglycemia in humans.

Interventions

Sponsors

National Center for Research Resources (NCRR)
Lead SponsorNIH

Study design

Allocation
NON_RANDOMIZED
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Clinically stable, insulin dependent islet transplant recipients and matched nondiabetic healthy controls

Contacts

Primary ContactPhilip E. Cryer, M.D.
pcryer@imgate.wustl.edu1-314-362-7635

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026